Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mydecine Innovations Group Inc. (MYCO.CN)

Mydecine Innovations Group Inc. (MYCO.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 19,729
  • Shares Outstanding, K 33,438
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 3.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.99
  • Price/Earnings ttm 14.75
  • Earnings Per Share ttm 0.04
  • Most Recent Earnings -0.01 on 03/31/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.450 +17.78%
on 08/06/20
0.850 -37.65%
on 07/14/20
-0.340 (-39.08%)
since 07/10/20
3-Month
0.310 +70.97%
on 05/11/20
1.150 -53.91%
on 06/08/20
+0.215 (+68.25%)
since 05/08/20
52-Week
0.040 +1,225.00%
on 03/17/20
1.150 -53.91%
on 06/08/20
-0.370 (-41.11%)
since 08/09/19

Most Recent Stories

More News
Mindleap Health(TM) Expands its Digital Mental Health Programs for Addiction, Psychedelic Integration and Holistic Wellness

Mydecine Innovations Group(TM) (CSE: MYCO) (OTC: NLBIF) (FSE:0NF) ("Mydecine"), is pleased to announce that its subsidiary, Mindleap Health(TM) ("Mindleap" or the "Company") based in Vancouver, British...

MYCO.CN : 0.530 (-10.17%)
NLBIF : 0.6150 (-6.82%)
Ex-Canopy Growth Geneticist Turns His Focus to Psychedelics -- CFN Media

Whitefish, Montana--(Newsfile Corp. - July 29, 2020) -   (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries,...

MYCO.CN : 0.530 (-10.17%)
CNFN : 0.0500 (unch)
Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)
Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

Mydecine Innovations Group Inc. Appoints Previous Red Bull Sports Marketing Director Jim Gunning as CMO

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)
Mindleap Health Signs Agreement with Brightmind to Launch Comprehensive Meditation Program

Mydecine Innovations Group Inc. (CSE: MYCO) (OTCMKTS: MYCOF) ("Mydecine" or the "Company") is pleased to announce that its subsidiary Mindleap Health Inc. ( "Mindleap" ) has signed an agreement dated...

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)
Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)
Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)
Psychedelic Compounds Could be Used in Mental Healthcare

There is a need for new antidepressants with a mechanism of action different from that of SSRIs and SNRIs to improve efficacy across several symptoms, reduce side effects, and provide sustained remission....

SRNE : 18.82 (+30.51%)
VFF : 6.31 (+5.87%)
ZYNE : 4.24 (+0.47%)
MYCO.CN : 0.530 (-10.17%)
Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc.

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc.

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)
Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

MYCO.CN : 0.530 (-10.17%)
MYCOF : 0.4001 (-6.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.610
1st Resistance Point 0.570
Last Price 0.530
1st Support Level 0.500
2nd Support Level 0.470

See More

52-Week High 1.150
Fibonacci 61.8% 0.726
Fibonacci 50% 0.595
Last Price 0.530
Fibonacci 38.2% 0.464
52-Week Low 0.040

See More

Business Summary

Mydecine Innovations Group Inc is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. Mydecine's experienced cross functional teams have the capabilities to oversee all areas of drug development...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar